AnaptysBio(ANAB)
SAN DIEGO, CABiotechnology
Focus: AnaptysBio is a San Diego-based public antibody therapeutics company focused on immuno-oncology and inflammatory diseases, competing in the mid-cap biotech space with a clinical-stage pipeline.
Profile data last refreshed 14h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About AnaptysBio
AI assessmentNot HiringNo open roles listed right now. Follow AnaptysBio to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from AnaptysBio's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$17M
Pipeline & Clinical Trials
Analysis of Peripheral Blood ILC2s and Th2 Cells in Response to ANB020
AsthmaClinical Trials (1)
NCT04256044Analysis of Peripheral Blood ILC2s and Th2 Cells in Response to ANB020
N/AHelp build intelligence for AnaptysBio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.